INMDInMode Ltd.

Nasdaq inmodemd.com


$ 18.48 $ 0.39 (2.15 %)    

Monday, 13-May-2024 15:59:59 EDT
QQQ $ 441.96 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.56 $ -2.45 (-1.12 %)
$ 18.49
$ 18.38
$ 0.00 x 0
$ 0.00 x 0
$ 18.34 - $ 18.68
$ 16.72 - $ 48.25
937,847
na
1.55B
$ 1.86
$ 7.85
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
05/03/2024 10:17:23

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

 inmode-q1-adj-032-misses-044-estimate-sales-8028m-miss-9302m-estimate

InMode (NASDAQ:INMD) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.44 by 27....

 inmode-defends-its-feminine-rejuvenation-patent-against-btl-industries-review-request

InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to th...

 barclays-maintains-overweight-on-inmode-lowers-price-target-to-33

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $34 to $33.

 btl-petitions-uspto-to-cancel-all-58-claims-of-us-patent-no-8961511-owned-by-the-company-inmode-ltd

BTL Industries, Inc., a leading provider of innovative medical aesthetic solutions, petitioned the U.S. Patent Office to cancel...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 needham-reiterates-hold-on-inmode
Needham Reiterates Hold on InMode
04/09/2024 15:53:24

Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) with a Hold.

 maxeon-solar-technologies-neogen-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 0.2% on Tuesday. Shares of Maxeon Solar...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 inmode-q4-adj-eps-071-beats-067-estimate-sales-12678m-beat-12504m-estimate

InMode (NASDAQ:INMD) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.67 by 5.97 ...

 earnings-scheduled-for-february-13-2024

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

 inmodes-earnings-a-preview
InMode's Earnings: A Preview
02/12/2024 16:01:26

 barclays-maintains-overweight-on-inmode-lowers-price-target-to-32

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $33 to $32.

 barclays-maintains-overweight-on-inmode-lowers-price-target-to-33

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $45 to $33.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION